1 of 1
Story summary
- A study from Washington University School of Medicine found that stopping GLP-1 drugs Ozempic and Wegovy increases the risk of heart attack, stroke, and death.
- Researchers tracked over 333,000 U.S. veterans with type 2 diabetes for three years to assess cardiovascular outcomes after discontinuation.
- Dr. Ziyad Al-Aly of Washington University School of Medicine notes that six-month gaps raise cardiovascular risk by 4%, while a two-year gap raises it by 22%.
